Companies whose shares are expected to trade actively in today are Morgan Stanley (NYSE:MS), Research In Motion Limited (NASDAQ:RIMM) (TSE:RIM), Sony Corporation (NYSE:SNE) (TYO:6758), Capital One Financial Corp. (NYSE:COF), Intel Corporation (NASDAQ:INTC) and NuPathe Inc (NASDAQ:PATH).
Morgan Stanley (NYSE:MS): The investment bank returned to the fourth quarter profit after suffering a net loss of $250 million in the same period of 2011. The institutional securities unit posted stronger than expected revenues. Shares surged 6.31 percent to $22.06 since the open.
Research In Motion Limited (NASDAQ:RIMM) (TSE:RIM): The Canadian smartphone maker is already helping its users adapt to the upcoming BlackBerry 10 platform. Shares of the company went up 4.69 percent to $15.61 in early trading after Jefferies said that the company will allow its email and messaging service known as BBM on Android and iPhone devices. Jefferies has increased its price target to $19.50 and changed its rating to buy from hold.
Sony Corporation (NYSE:SNE) (TYO:6758): The Japanese electronics company is selling its New York headquarters for $1.1 billion. The company said it will complete the deal by the end of March. American shares of the company rose 5.71 percent to $12.59.
Capital One Financial Corp. (NYSE:COF): Though its fourth quarter earnings and revenues demonstrated strong growth, the company’s revenues and earnings missed analysts’ estimates due to operating expenses and loan-loss provisions. Shares dipped 7.44 percent to $57 in early trading session.
Intel Corporation (NASDAQ:INTC): The chipmaker’s profits declined 27 percent amid weakening demand of personal computers. Intel has suffered due to consumers shifting towards smartphones and tablets. Shares were down 5.78 percent to $21.37.
NuPathe Inc (NASDAQ:PATH): The company said that U.S. Food and Drug Administration has approved its Zecuity migraine patch. The battery-powered patch will be launch later this year. Shares surged 7.85 percent to $3.55 in early trading session.
Another company to watch out for is Trius Therapeutics, Inc. (NASDAQ:TSRX). The company is offering 6.3 million shares at $4.75. Shares plunged 8 percent to $4.80 in early trading.
